
The ABPI has confirmed that CEO Stephen Whitehead has left the organisation. Speaking on behalf of the Board, John Kearney, …

According to The Association of the British Pharmaceutical Industry (ABPI) the dominant issue in 2015 will be the affordability and …

The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …
The ABPI has named its new Medical, Innovation and Research director as Dr Bina Rawal, who will join the trade …

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

